Autoimmune pancreatitis (AIP) is thought to be an immune-mediated infl ammatory process, directed against the epithelial components of the pancreas. The objective was to identify novel markers of disease and to unravel the pathogenesis of AIP.
INTRODUCTION
Autoimmune pancreatitis (AIP) is a unique disease within the spectrum of infl ammatory changes of the pancreas ( 1, 2 ) . Despite great eff orts, it remains a big challenge to establish its diagnosis ( 3 ) . Th e clinicopathologic features are suggestive of an immunerelated etiopathogenesis ( 1, 2 ) . Th is assumption is supported by the histopathological features of the disease ( 4 -6 ) , its frequent association with other autoimmune disorders ( 6, 7 ) , the demonstration of autoantibodies, ( 8, 9 ) and the response to steroid treatment ( 10, 11 ) . Moreover, thymectomized mice immunized with carboanhydrase-II or lactoferrin develop a disease that closely resembles AIP ( 12 ) . Circulating antibodies in AIP include autoantibodies against carboanhydrase-II, lactoferrin, and nuclear and smooth muscle antigens (ANA, ASMA) ( 8, 9 ) . High serum immunoglobulin (Ig) levels were already reported 50 years ago in the initial description of AIP ( 13 ) . Elevated IgG4 levels are currently regarded as the most sensitive serum parameter for diagnosing AIP ( 14, 15 ) and increased numbers of IgG4-positive plasma cells help to establish the histopathological diagnosis ( 16 ) . To further identify the key proteins targeted by the infl ammatory process in AIP, particularly those that may be indicative of an involvement of the acinar cells, we searched for related changes in the RNA and protein expression profi les of pancreatic tissue from AIP patients and compared them with those from specimens of patients with non-AIP chronic pancreatitis (non-AIP CP). We found a severe downregulation, both at the RNA and protein level of pancreatic proteases, especially trypsinogens, that was associated with a reduction in the acinar cell numbers in AIP tissues. We were able to corroborate these fi ndings in an experimental mouse model of AIP ( 17 ) . In addition, we detected high-titer autoantibodies against trypsinogensin patients with AIP.
METHODS

Tissue and serum samples
Human pancreatic tissue samples ( n = 22) were obtained during surgery, immediately snap frozen, and stored in liquid nitrogen. Th e samples were obtained consecutively, however, only tissue with approved preservation was taken. Additional samples from the same tissues were fi xed in formalin and embedded in paraffi n. Th e diagnosis of AIP ( n = 12) or non-AIP CP ( n = 8) was based on established histopathological criteria ( 5 ) . Th e pancreas from two healthy organ donors served as controls. Patient characteristics are listed in Supplementary Table S1 online . In addition, serum samples from 19 AIP patients (58 % male, mean age: 46 years), and 23 non-AIP CP patients (78 % male, mean age: 48 years), and 121 healthy subjects (49 % male, mean age: 28 years) were collected. In eight patients, the diagnosis of AIP was based on the histopathological fi ndings in the resection specimens ( 5 ) . In the remaining 11 patients, the HiSORT criteria were applied ( 7 ) that allowed to establish the diagnosis of AIP based on a positive fi ne needle biopsy (six patients) ( 18 ) , an association with other autoimmune diseases (fi ve patients), radiological fi ndings, and response to steroid therapy (all patients). Of the non-AIP CP patients, 18 / 23 had a history of alcohol abuse and 5 / 23 an idiopathic or hereditary pancreatitis. CP was diagnosed at least 3 years before taking the samples. Eight patients underwent pancreatic surgery (7 / 23 with pancreatic head resection and 1 / 23 with left sided pancreas resection), whose indication was either pain (4 / 23), pseudocyst (1 / 23), or stenosis of the bile duct (3 / 23) . Th e local institutional review boards at the University of Heidelberg, Germany, the University of Kiel, Germany, and the University of Verona, Italy, approved the project. Written informed consent was obtained before the procurement of the biological samples.
From C57BL / 6 mice infected with the murine leukemia retrovirus LP-BM5, ( 19 ) which developed symptoms and histological fi ndings similar to human AIP ( 17 ), fresh-frozen pancreatic tissue samples ( n = 6) were obtained. Pancreatic tissues ( n = 6) from noninfected mice served as controls.
Microarray gene expression profi ling
Total RNA was prepared from human pancreatic tissue using commercially available systems (RNeasy kit, Qiagen, Hilden, Germany). Tissue was taken from the same specimen piece as for proteome analysis. RNA samples were labeled according to the supplier ' s instructions (Aff ymetrix, Santa Clara, CA) and hybridized overnight (45 ° C) to HG U133A arrays (22,283 probe sets, Aff ymetrix) and scanned (GeneArray Scanner 2500, Hewlett Packard, Palo Alto, CA). Th e microarray data are deposited at ArrayExpress ( http://www.ebi.ac.uk/arrayexpress/ ) under the entry name E-MEXP-804.
Analysis of microarray data
Data normalization was performed by vsn ( 20 ) using CEL (Celera) intensity fi les. Signifi cance analysis of microarrays ( 21 ) was used on the vsn-transformed data for calculating P values. Genes with a fold change > 2 or < − 2 and a P value < 0.05 were considered to be signifi cantly altered between AIP and non-AIP CP ( Supplementary Table S4 ). Two-dimensional hierarchical cluster analysis was carried out with the diff erentially regulated genes. Th e clustering was done for the Manhattan distance in combination with the complete linkage algorithm ( 22 ) .
Using the Gene Ontology (GO) database ( http://www.gene ontology.org ), we chose a minimum similarity depth of eight for visualization of gene distances in functional GO annotation. All genes were represented by nodes in the resulting graph, and the edges connecting the two nodes were being compared. Th e Bioconductor package GOstats was used to calculate the distances in similarity depth ( http://www.bioconductor.org ). Visualization of the graph was done with Cytoscape ( http://www.cytoscape.org ). Function and pathway analyses were performed using the database for annotation, visualization, and integrated discovery (DAVID) platform ( 23 ) .
Proteome analysis
Proteins were extracted using a procedure described by Klose ( 24 ) modifi ed for pancreatic specimens ( 25 ) by addition of protease inhibitors (Complete Mini EDTA-free (Roche Applied Science, Mannheim, Germany), pepstatin, phenylmethylsulphonyl fl uoride). Samples for diff erential in-gel electrophoresis (DIGE) analysis were labeled with CyDye DIGE fl uor minimal dyes (Amersham L ö hr et al.
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Biosciences, Freiburg, Germany). Samples were loaded into linear immobilized pH gradient (IPG) strips (Immobiline DryStrips pH 4 -7; Amersham Biosciences) using 75 μ g total protein / strip. Isoelectric focusing was performed on an IPGphor unit (Amersham Biosciences) for a total of 125 kVh. Before second dimension separation, proteins were reduced by dithiothreitol and alkylated by iodoacetamide. SDS -PAGE was performed on 12.5 % polyacrylamide gels running on a vertical Hoefer DALT Electrophoresis Tank (Amersham Biosciences) ( 25 ) . Each sample was run at least three times to diminish experimental variability, to monitor the reproducibility, and to check the integrity of the frozen tissue samples.
Th e separated proteins were visualized by modifi ed silver staining compatible with MALDI-TOF-MS (Matrix Assisted Laser Desorption Ionization -Time Of Flight Mass Spectrometry) ( 26 ) or by fl uorescence laser scanning (FLA-5100 imaging system; Fujifi lm Europe, D ü sseldorf, Germany) according to the wavelengths of the CyDye. Silver-stained gels were digitized using a GS-800 densitometer (Bio-Rad, Munich, Germany) and imported into a two-dimensional gel image analysis program. PDQuest 7.1 (BioRad) and Delta two-dimensional 3.4 (for DIGE analysis; Decodon, Greifswald, Germany) were used to locate and quantify protein spots and match spots through the gels. Th e statistical comparison of individual protein abundances was performed with Student ' s ttest within the soft ware programs. Experimental M w and pI values were calculated internally. Proteins that showed variable changes or were present only in some of the gels were not reported.
Protein identifi cation by MALDI-TOF-MS
Silver or fl uor-stained gel pieces were excised manually or by an automated spotpicker (Bruker Daltonics, Bremen, Germany) and subjected to in-gel digestion. Proteins were reduced, alkylated, and digested with sequencing-grade-modifi ed trypsin (Promega, 
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Mannheim, Germany) as described ( 27 ) . Tryptically digested protein samples were analyzed with MALDI-MS in the positive ion mode (Autofl ex II time-of-fl ight instrument, Bruker Daltonics). Tryptic, monoisotopic peptide masses were run against the NCBInr or SwissProt nonredundant protein sequence database (Mascot; Matrix Science, London, UK) using the peptide mass fi ngerprint method. Identifi cation was based on a signifi cant Mascot score ( P < 0.05) and, in most cases, on at least fi ve matching peptides with a protein sequence coverage of > 20 % . Th e experimental M w and pI values determined from the protein pattern had to be in agreement with the theoretical value of the identifi ed proteins.
Immunohistochemistry
Formalin-fi xed pancreatic tissue from 20 patients was cut into 2 μ m sections and stained with an anti-trypsin monoclonal antibody (Ventrex Laboratories, Portland, OR; 1:100), and polyclonal antibodies against cleaved caspase 3 (Santa Cruz Biotechnology, Santa Cruz, CA: 1:100). Antigen retrieval was performed for 2 min 45 sec in a pressure cooker with citrate buff er. Th e immunostaining was carried out using the avidin -biotin -peroxidase complex method. Apoptotic cells were defi ned on the basis of cell shrinkage, nuclear chromatin condensation, and fragmentation.
Western blot
Protein samples from the same specimens as used for proteomics were subjected to 1D gel electrophoresis and blotted as described before ( 28 ) . Depending on the antibodies used subsequently, lysates were mixed with either reducing or nonreducing SDS sample buff er and boiled for 5 min. Equal protein amounts were separated by SDS -PAGE and transferred into a PVDF membrane (polyvinylidene fl uoride, Roche) using standard protocols ( 28 ) . Blot membranes were blocked in Tris-buff ered saline (10 m M Tris, 10 m M NaCl) containing 5 % nonfat dry milk (New England Biolabs, Frankfurt / a M, Germany) and probed with the respective antibodies. Th e following antibodies were used: trypsin (H-101, rabbit polyclonal, 1:2,000, Santa Cruz, Heidelberg, Germany), trypsin 1 / PRSS1 (MAB3848, mouse monoclonal, 1:250, R & D Systems, Wiesbaden, Germany), trypsin 2 / PRSS2 (MAB3586, mouse monoclonal, 1:500, R & D Systems), β -actin (AC-15, mouse monoclonal, 1:10,000, Sigma, Munich, Germany), and actin (A-2066, rabbit polyclonal, 1:1,000, Sigma). Goat anti-mouse HRP and goat antirabbit HRP (1:5,000, both from Pierce, Bonn, Germany) were used as detection antibodies. SuperSignal West Femto Maximum Sensitivity Substrate (Pierce) was used for visualization.
Serum trypsinogen immunoassay
Th e serum concentrations of anionic trypsinogen (PRSS2) were determined with a two-site noncompetitive sandwich immunoassay. Mouse monoclonal antibody specifi c to PRSS2 was purifi ed with sepharose protein A and used as the primary " capture " antibody, whereas the secondary antibody was a rabbit polyclonal antibody. Antibodies were isolated from animals repeatedly immunized against PRSS2. PRSS2 was purifi ed from human pancreatic juice by affi nity and ionic exchange chromatography. Wells of microtiter plates were coated with capture mAb (10 μ g / ml)
in bicarbonate buff er (0.1 M, pH 9.6) overnight at 4 ° C. Diluted human serum (1:400) and PRSS2 standards were added to precoated wells in triplicates. Secondary Ab was added (diluted 1:1,000 in PBS / Tween, 1 h) followed by peroxidase-conjugated anti-rabbit IgG (goat, Calbiochem, Los Angeles, CA; 1:1,000 in PBS / Tween, 30 min); 2,2 ′ -azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS; 1.5 m M in 50 m M citrate buff er, pH 4.0, 0.007 % H 2 O 2 ) was used as the peroxidase substrate. Th e reaction was monitored at 405 nm and stopped aft er 10 min with oxalic acid (0.15 M ). Th e serum concentration of human cationic trypsinogen (PRSS1) was determined with the Elegance Neonatal IRT ELISA kit (Bioclone, Marrickville, Australia), based on specifi c monoclonal antibodies raised against PRSS1. A normal range of 4.2 -31.5 μ g / l (mean 11.5 μ g / l) for serum PRSS2 and a normal range of 11.4 -38.0 μ g / l (mean 20.9 μ g / l) for serum PRSS1 were established earlier ( 29 ) .
Serum trypsinogen and SPINK1 autoantibodies
Sandwich ELISAs were established for human IgG autoantibodies against all three trypsinogen isoforms and SPINK1. Recombinant human PRSS1 ( 30 ), PRSS2 ( 31 ), PRSS3 ( 32 ) , and PSTI ( 33 ) were used. Recombinant trypsinogens (500 ng per well) and SPINK1 (400 ng), diluted in sodium carbonate buff er (Merck, Darmstadt, Germany, pH 9.6) were incubated overnight at 4 ° C. Serial dilutions of human IgG (Octapharma, Langenfeld, Germany) ranging from 4 to 1,000 pg / ml were used as standards. Blocking was performed using 3 % bovine serum albumin (BSA) in PBS / Tween. Sera from patients with AIP and non-AIP CP and sera from healthy blood donors were diluted 1:1,600 (trypsinogen) or 1:600 (PSTI) in PBS / Tween with 1 % BSA and incubated for 2 h at 37 ° C. A polyclonal goat anti-human IgG (H + L) peroxidase conjugate (1:5,000, Dianova, Hamburg, Germany) was used for the detection of bound Igs and staining with tetramethylbenzidine (TMB) substrate kit (Pierce, Rockford, IL). All samples were run in triplicate. Anti-trypsinogen IgG concentrations were normalized to total protein concentrations. Th e protein content was measured using a BCA assay (Perbio Science, Bonn, Germany).
Bioinformatic analysis of serum antibody data
Logistic regression was used for pairwise separation of the three classes: AIP, non-AIP CP, and healthy controls. Th e models were fi tted using conjugate gradient descent, with leave-one-out cross-validation for each classifi cation pair (AIP vs. control, non-AIP CP vs. control, and AIP vs. non-AIP CP). Sensitivity, specifi city, and accuracy were computed from the cross-validation runs. Mean regression coeffi cient values were used to analyze the signifi cance of inputs.
RESULTS
Histological and immunohistochemical characterization
Th e pancreatic resection specimens obtained for histopathological examination and used in the RNA and protein profi ling studies showed the typical features of either AIP or non-AIP CP ( 5, 34 ) . Briefl y, in 12 specimens, dense periductal, inter lobular, and interacinar lymphoplasmacellular infi ltrates were found in association with a storiform fi brosis and an obstructive phlebitis. Th ese changes that Table S1 ). Th e degree of reduction of the acinar cell numbers by fi brosis was estimated semiquantitatively in sections immunostained for trypsin. In the AIP cases there was an 80 -95 % loss of acinar cells compared with normal pancreatic tissue ( Figure 1a ). In the few remaining acinar cells, single apoptotic fi gures and / or cytoplasmic immunohistochemical positivity for caspase 3 were seen ( Figure 1b ) . In non-AIP CP the pancreatic changes were characterized by a patchy, predominantly interlobular fi brosis that was not as cellular as in AIP, containing only few lymphocytes, plasma cells, and macrophages. Th e loss of acinar cells amounted to 40 -80 % . Apoptotic fi gures and caspase 3-positive acinar cells were not observed.
RNA expression profi les
RNA expression profi ling was performed in pancreatic tissues from resection specimens of 4 of the 12 AIP and 5 of the 8 non-AIP CP patients using microarray technology. In all, 358 of the 22,283 genes were diff erentially expressed ( Supplementary Table S4 ); 272 genes were upregulated in AIP compared with non-AIP CP, including those encoding various Igs, chemokines, major histocompatibility complex proteins, interleukin receptors, TNF receptors, CD 25, CD28, CTLA-4, Fox-P3, matrix metallopeptidases 9 and 12, S100 calcium-binding protein A8 / A9 ( 36 ), granzyme, and fi ve members of the cathepsin family ( Supplementary Table  S4a ). In contrast, the expression of 86 genes, including the genes of several proteases (anionic and cationic trypsinogen, mesotrypsinogen, chymotrypsinogen, (pro)elastase), was downregulated in AIP. Furthermore, transcripts of amylase, lipase, REG1, albumin, and serine protease inhibitors were less abundant in AIP than in non-AIP CP ( Supplementary Table S4b ). Th e individual samples had most of the outlying genes in common. Th ere was no diff erence between type 1 and type 2 AIP. Two-dimensional unsupervised hierarchical clustering showed distinct class separation of the four patients with AIP from the fi ve with non-AIP CP ( Figure 2a ) . We used the GO Database and Kyoto Encyclopedia of Genes and Genomes pathway analysis to cluster up-and downregulated genes according to function or pathway. Analysis using a GO depth of fi ve showed that most of the upregulated genes in AIP could be ascribed to (auto)immune responses (43 % ), signal transduction (34 % ), and apoptosis (8 % ). Other upregulated genes encoded for mediators in immune defense pathways and cell adhesion (26 genes), major histocompatibility complex 1, and major histocompatibility complex 2 pathways (21 genes), natural killer cell-mediated cytotoxicity (17 genes), and the T-cell receptor signaling pathway (13 genes). Th e 86 downregulated genes in AIP could be mapped predominantly to metabolic processes (63 % ). Most of these genes encoded catalytic active enzymes, especially proteases and lipases, from acinar cells.
To gain more detailed information, we performed a visualization of distances in functional GO annotation between the genes, because a measure of the degree of relationship can be obtained by comparing the number of nodes that two genes share on the same GO path ( 37, 38 ) . Calculating the relationship between the 358 diff erentially regulated genes showed that 79 genes had a similar depth ( ≥ 8) as at least one other gene. Th irty-three of the most diff erentially regulated genes ( Figure 2b ) were found to be involved in one of six biological processes: proteolysis and peptidolysis, regulation of transcription, induction of apoptosis, actin cytoskeleton organization and biogenesis, and calcium ion homeostasis.
Protein expression profi les
In tissue samples from12 AIP and 6 non-AIP CP specimens and 14 tissue samples from two pancreas specimens from healthy subjects, there was a striking similarity of the individual protein expression patterns within the diff erent groups and only minor interindividual diff erences. About 1,000 -1,500 protein spots were detected on 
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silver-stained two-dimensional gels. A master gel was obtained for human pancreatic tissue matching the spot data from the actual gels ( Supplementary Figure S1 ). More than 100 characteristic protein spots per replicate group, present in all three groups, were picked as landmark proteins. MALDI-TOF MS identifi cation showed a matching accuracy of nearly 100 % . From these characteristic protein spots a protein database of the normal human pancreas was established ( Supplementary Figure S1 ; Supplementary Table S2 ). As the AIP cases showed a distinct pattern with very little interindividual diff erences that showed a clear-cut separation from both non-AIP CP and normal pancreas, it was not possible to distinguish between the two subtypes of AIP on the basis of the two-dimensional protein pattern. In a second series, samples of each tissue type were pooled to reduce individual diff erences. More than 20 proteins were diff erentially expressed to a signifi cant degree in AIP (fold change > 2, P < 0.01). We found a signifi cant reduction in 5 protease precursors in 11 of 12 AIP tissues. Th ese were cationic trypsinogen (PRSS1), anionic trypsinogen (PRSS2), mesotrypsinogen (PRSS3), chymotrypsinogen B, and (pro)elastase 3B (CELA3B) ( Figure 3 ). In eight samples, PRSS1, PRSS3, and CELA3B were absent or visible only in traces ( < 5 % compared with normal pancreatic tissue), in three other samples, they were markedly reduced (25 -50 % ). Western blot confi rmed the downregulation and proper size of both PRSS1 and PRSS2 ( Figure 1a ). Non-AIP CP samples showed only a slight decline in CELA3B and no signifi cant change in the intensity of PRSS1, PRSS2, and PRSS3.
Other changes in the protein expression patterns concerned the regenerating protein I (REG1) isoforms, whose spot pattern seen in the normal pancreas ( Figure 3a ) was absent in AIP and reduced in non-AIP CP (1 -70 % ), and 14 further proteins that were diff erentially expressed in AIP exclusively or in both types of CP. Th e latter proteins included cathepsin D (heavy chain) and thymidine phosphorylase (platelet-derived endothelial cell 
especially for cationic (PRSS1) and anionic trypsinogen (PRSS2) ( Figure 4a ). Only the relation between PRSS1 and PRSS2, which is 1:3 in healthy individuals and inverted to 2:1 in non-AIP CP, ( 40 ) was found to be 1:2 in AIP.
Autoantibodies against trypsinogen and SPINK1
As we found not only the ducts ( 9 ) but also the acinar tissue severely aff ected in AIP, we searched for autoantibodies against trypsinogen isoforms and the trypsin inhibitor PSTI in patients with AIP (data listed in Supplementary Table S5 ). We found signifi cantly elevated levels of IgG directed against PRSS1 and PRSS2, but not PRSS3, in AIP compared with non-AIP CP and healthy subjects ( Figure 4b ). We also detected autoantibodies against PSTI in AIP ( 41 ). A logical regression analysis coupled with leave-one-out cross-validation showed that the autoantibody serum data had a predictive accuracy of 80 % for distinguishing patients with AIP from those with non-AIP CP, and an accuracy of 86 % for AIP patients vs. healthy controls. Th e sensitivity of the autoantibody test was 68 % for AIP vs. non-AIP CP and 79 % for AIP vs. controls. Th e specifi city was 90 % for AIP vs. non-AIP CP and 95 % for AIP vs. controls ( Supplementary  Table S6 ).
growth factor), which were signifi cantly upregulated in AIP tissues compared with the normal pancreas and non-AIP CP ( Table 1 ) . A selection of evaluated candidate molecules that emerged from the expression profi ling (both transcriptomics and proteomics) as relevant to the pathogenesis of acute and CP and pancreatic physiology in general ( 39 ) was chosen for further analysis.
Protein expression profi les of C57BL / 6 mice
With two-dimensional diff erential in-gel electrophoresis (DIGE), 20 protein spots were diff erentially expressed in murine leukemia retrovirus LP-BM5-infected mouse pancreas (fold change > 1.2, P < 0.05) ( Figure 3c ). As in human AIP, isoforms of serine proteases (murine trypsinogen-8 and -20, chymotrypsinogen B, (pro)elastase 3B) were signifi cantly downregulated ( Table 2 and  Supplementary Table S3 ).
Trypsinogen serum levels
As proteases were reduced at the RNA and protein level, we measured the trypsinogen concentrations in the serum of 19 patients with AIP, 23 patients with non-AIP CP, and 121 healthy subjects. Th is showed no signifi cant diff erences between the three groups, 
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DISCUSSION
AIP is a disease that predominantly involves the pancreatic ducts and in many cases the bile ducts ( 42 ) , with characteristic histopathology and typical changes on endoscopic retrograde cholangio-pancreatography and magnetic resonance cholangio-pancreatography. Th e histopathological features of AIP include a storiform fi brosis, dense periductal and also diff use lymphoplasmacellular infi ltrates, obliterative venulitis, and the presence of numerous CD4 and CD8 lymphocytes ( 5, 8 ) . Recently, two subtypes of AIP were described: lymphoplasmacytic sclerosing pancreatitis (also called AIP type 1) with presence of IgG4-posivite cells and idiopathic duct-centric chronic pancreatitis or AIP with so-called granulocyte-epithelial lesions (also called AIP type 2) ( 5, 35, 43 ) . Th ese features have raised the possibility that AIP is an immune-mediated infl ammatory process. Autoantibodies against carboanhydrase-II, one of the main enzymes of bicarbonate-secreting duct cells, have been reported in AIP patients ( 9 ) , and supported the notion that in AIP primarily the pancreatic duct epithelium is targeted by the immune cells ( 44 ) . Our data suggest that acinar cells and their protein components also seem to be targeted by the infl ammatory process. Th is is associated with the occurrence of autoantibodies against trypsinogens, which may be clinically useful for the diagnosis of AIP.
As we chose to analyze nonmicrodissected pancreatic tissue, a certain degree of heterogeneity among the various samples was expected. However, the two-dimensional protein patterns that we obtained from the various probes were strikingly similar. Th erefore, our global RNA expression analysis showed clear diff erences between the AIP tissues in comparison with the non-AIP CP and normal pancreas tissues. We found 272 upregulated genes and 86 downregulated genes. Among the upregulated genes, we identifi ed several encoding for Igs and proinfl ammatory as well as immunologically active chemokines and their receptors. Th e downregulated genes included those encoding for pancreatic proteases such as trypsinogens, chymotrypsinogen, and (pro)elastase, as well as amylase and lipase. Other downregulated genes that might also be of interest in conjunction with AIP were regenerating protein 1 (REG1 / PAP), which acts anti-infl ammatory ( 45 ) . On the protein level, several REG1 isoforms are lacking in AIP. Low REG1 levels could, therefore, contribute to the overwhelming infl ammatory infi ltrate seen in AIP ( 5 ) .
Th e profound downregulation of the genes was paralleled by a similar loss of the respective gene product. Using protein profi ling either no trypsinogen and (pro)elastase 3B or only traces of them were found in 8 of 12 tissue specimens from AIP patients. In three other specimens, these proteases were reduced to 25 % compared with the values observed in non-AIP CP or normal pancreatic tissues. Th ese data suggested a severely restricted synthesis and production of proteases and other pancreatic enzymes in AIP in comparison to controls or pancreatitis of nonimmune origin. As these proteins are a product of acinar cells, we analyzed the same AIP and non-AIP CP tissues that had been analyzed for their protein profi le and content, for the presence and number of acinar cells using immunohistochemical staining for trypsin that was controlled by western blotting. Th ese analyses showed that the number of trypsin-positive acinar cells in AIP and non-AIP CP correlated with the amount of trypsin detected by protein profi ling in the respective samples. Although in the AIP tissues the number of acinar cells was reduced by 80 -95 % , in non-AIP CP the acinar tissue compartment was only diminished by 40 -60 % of that of the normal pancreas. A similar reduction in acinar cell numbers and content of proteases was found in the animal model of AIP ( 17 ) that we used for comparison with human AIP. Such a signifi cant reduction of proteases suggests that the infl ammatory processes would completely and, therefore, irreversibly destroy the acinar cells in AIP. However, most AIP patients respond well to steroid therapy, and the production of digestive enzymes is restored in the acinar cells ( 46 ) . Th erefore, we conclude that the protease defi ciency is not only a matter of a reduction in the number of acinar cells. Th e signifi cant reduction might refl ect the degree of infl ammatory intensity that could also vary in diff erent areas of the pancreas ( 5, 47 ) .
Owing to the loss of acinar cells in AIP we analyzed the serum levels of circulating trypsinogen and compared activities in AIP with those in non-AIP CP and healthy controls. These data indicate that the trypsinogen serum levels of AIP and non-AIP CP patients were both within the normal range and not affected by the acinar cell loss. An explanation for this finding could be that in most cases the patchy tissue involvement of AIP and non-AIP CP leaves enough viable acinar cells in the remaining pancreas to maintain normal serum levels of trypsin and other pancreatic enzymes. There is, however, as yet no ready explanation why the relation between cationic and anionic isoforms of trypsin ( 40 ) is changed in AIP compared with non-AIP CP.
Th e cause of the substantial loss of acinar cells and their replacement by fi brosis during the course of AIP is not known. In non-AIP CP caused by excessive alcohol consumption focal necrosis of the pancreatic parenchyma is followed by activation of stellate cells and myofi broblasts, which then produce extracellular matrix ( 48 ) . Th e histopathological features of AIP suggest an immune-related attack against various cellular components of the pancreas. According to our data this attack is not only directed to the ductal cells and their components but also against the acinar cells, as we found high-titer autoantibodies against trypsinogens (PRSS1 and PRSS2) and PSTI ( 41 ) in AIP patients. As non-AIP CP patients lacked these antibodies, the development of autoantibodies against trypsinogens and the trypsin inhibitor PSTI seems to be typical for AIP. Further evidence that the proteins of the acinar cells are targeted in AIP is provided by the fi ndings of a recent study in AIP patients showing autoantibodies against an ubiquitin subunit (UBR2), which is another particular acinar protein ( 49 ) .
Th e initial events triggering AIP are not known. It may be speculated that the pancreatic cells are primarily injured either by a virus or by another infectious agent that causes altered cellular proteins, which, in turn, become the targets of immune-L ö hr et al.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
3 Autoimmune pancreatitis (AIP) is an infl ammatory disease of the exocrine pancreas with the features of an immunemediated process.
3 Elevated serum levels of IgG and IgG4 are of diagnostic relevance, in many (up to 50 % ) but not all patients.
3 Autoantibodies against ductal antigens (carbonic anhydrase 2, lactoferrin) have been described earlier.
3 Recently, autoantibodies against UBR2, an acinar protein, have been reported. mediated processes. Such a pathogenetic mechanism was suggested for the virus-induced AIP mouse model ( 17 ) in which we found secretory protease defi ciencies strikingly similar to the situation in human AIP. Such an infection could induce a molecular mimicry that subsequently produces an autoimmune reaction -a process that has been also recently be discussed for UBR2, because it shows homology to the plasminogen-binding protein of Helicobacter pylori ( 49 ) , which had already been suggested as a causative agent, based on a homology between the cag A and the carbonic anhydrase 2 ( 50 ). However, we could not detect H. pylori in the pancreas of patients with various diseases including AIP ( 51 ) .
Whether in such a scenario the demonstrated autoantibodies against trypsin isoforms, PSTI and UBR2, have any significant role in the destruction of acinar cells remains to be determined. It seems, however, that the acinar cells in AIP undergo cell death through apoptosis because we found apoptotic bodies in individual cells that also stained for the apoptosis-related enzyme caspase 3 and morphologically corresponded to acinar cells.
In summary, our study shows that acinar cells, in addition to ductal cells, are target of the immune-related infl ammatory process-characterizing AIP. Clinically, the loss of the acinar cells is associated with elevated antibody titers for PRSS1, PRSS2, and PSTI, Th e detection of these antibodies by ELISA may help to distinguish AIP from other types of pancreatitis such as alcoholic pancreatitis. It seems that the loss of acinar cells and the occurrence of autoantibodies to trypsinogens are fi ndings typical for both subtypes of AIP, as we failed to detect any clear diff erences regarding these parameters between the so called subtype 1 and subtype 2 AIP.
